BIND Therapeutics to Present at the UBS Global Healthcare Conference
5/6/2013 6:55:15 AM
More...
|
AstraZeneca PLC (AZN) Signs $200 Million Deal With BIND Therapeutics for Cancer Drug
4/22/2013 7:19:42 AM
More...
|
BIND Therapeutics to Present at the Needham and Company 12th Annual Healthcare Conference
4/22/2013 6:43:16 AM
More...
|
BIND Therapeutics Presents Positive Clinical Data at the American Association for Cancer Research 2013 Annual Meeting for Lead Accurin Candidate, BIND-014, in Cancer Patients
4/9/2013 1:54:54 PM
More...
|
BIND Therapeutics Announces Global Collaboration With Pfizer Inc. (PFE) to Develop and Commercialize Multiple Accurins
4/3/2013 6:50:11 AM
More...
|
Reflecting Its Growth, BIND Biosciences Changes Name to BIND Therapeutics
4/2/2013 9:59:48 AM
More...
|
BIND Biosciences, Inc. Selected for Oral Presentation of BIND-014 Clinical Data at American Association for Cancer Research 2013 Annual Meeting
3/26/2013 11:11:27 AM
More...
|
BIND Biosciences, Inc. to Present at Upcoming 2013 Scientific Conferences
3/6/2013 7:03:05 AM
More...
|
BIND Biosciences, Inc. to Present at the Cowen and Company 33rd Annual Health Care Conference
2/14/2013 6:57:33 AM
More...
|
BIND Biosciences, Inc. Secures $8.7 Million
2/13/2013 8:55:51 AM
More...
|
|